Literature DB >> 7532408

Characterization of the 5' region of the CD10/neutral endopeptidase 24.11 gene.

H Haouas1, D Morello, A Lavenu, M Billard, C Jasmin, C Boucheix.   

Abstract

We have characterized the 5' region of the CALLA/CD10 gene which has been shown to be identical to the membrane-associated enzyme neutral endopeptidase 24.11 (NEP). There is no CAAT or TATA box in the 5' flanking region, upstream of exon 1, but a GC rich region with several Sp1 binding sites. We have detected several putative initiation transcription sites by primer extension and by nuclease S1 analysis. Moreover by reverse transcriptase-polymerase chain reaction, we demonstrated the existence of a new exon: exon 1bis. This exon can be alternatively spliced as has already been described for exon 1 and exon 2.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7532408     DOI: 10.1006/bbrc.1995.1275

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Identification and functional characterization of pVHL-dependent cell surface proteins in renal cell carcinoma.

Authors:  Gunther Boysen; Damaris Bausch-Fluck; Claudio R Thoma; Anna M Nowicka; Daniel P Stiehl; Igor Cima; Van-Duc Luu; Adriana von Teichman; Thomas Hermanns; Tullio Sulser; Barbara Ingold-Heppner; Niklaus Fankhauser; Roland H Wenger; Wilhelm Krek; Peter Schraml; Bernd Wollscheid; Holger Moch
Journal:  Neoplasia       Date:  2012-06       Impact factor: 5.715

2.  Association of neprilysin polymorphism with cerebral amyloid angiopathy.

Authors:  M Yamada; N Sodeyama; Y Itoh; A Takahashi; E Otomo; M Matsushita; H Mizusawa
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-06       Impact factor: 10.154

3.  A neprilysin polymorphism and amyloid-beta plaques after traumatic brain injury.

Authors:  Victoria E Johnson; William Stewart; David I Graham; Janice E Stewart; Amy H Praestgaard; Douglas H Smith
Journal:  J Neurotrauma       Date:  2009-08       Impact factor: 5.269

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.